Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement

Exicure has until December 2, 2026 to raise stockholders’ equity to Nasdaq’s required level or face potential delisting action.

Rhea-AI Summary

Exicure (XCUR) received a Nasdaq extension until December 2, 2026 to regain compliance with Nasdaq Listing Rule 5550(b)(1) on minimum stockholders’ equity.

The rule requires at least $2.5 million in stockholders’ equity, and Exicure previously also failed Nasdaq’s alternative continued listing standards based on market value of listed securities or net income from continuing operations. Under the extension, Exicure must complete its compliance initiatives and publicly demonstrate compliance by the deadline. Nasdaq will monitor compliance, and failure to meet the terms may lead to a delisting determination, which Exicure could appeal.

Positive

• Nasdaq extension granted to December 2, 2026 to regain equity compliance

Negative

• Non-compliance with $2.5 million minimum stockholders’ equity requirement
• Previously failed alternative listing standards for market value and net income
• Risk of Nasdaq delisting if compliance is not achieved by the deadline

Argus 15 min delay

-6.87% vs previous close $1.22 last price 1.3x rel. volume Open Argus

Details

Market Reaction – XCUR

$1.22 $1.26 Day Range

$7.99M Market Cap

Following this news, XCUR has declined 6.87%, reflecting a notable negative market reaction. The stock is currently trading at $1.22.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

On June 10, 2026, XCUR’s prior Nasdaq equity-deficiency notice was followed by a 2.17% 24-hour gain;...

Analysis

On June 10, 2026, XCUR’s prior Nasdaq equity-deficiency notice was followed by a 2.17% 24-hour gain; the current extension advances that same compliance matter but does not confirm restoration.

Key Figures

Compliance extension deadline: December 2, 2026 Minimum stockholders’ equity: $2.5 million

Compliance extension deadline

December 2, 2026

Deadline to publicly demonstrate compliance with Nasdaq’s equity requirement

Minimum stockholders’ equity

$2.5 million

Nasdaq Listing Rule 5550(b)(1) requirement

Historical Context

1 past event · Latest: Jun 10

1 event

1. Jun 10

   Nasdaq deficiency notice

   24h Move

   +2.2%

   Nasdaq cited failure to meet the $2.5 million stockholders’ equity requirement

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WILMINGTON, Del., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) (“Exicure” or the “Company”) today announced that, on September 10, 2026, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company an extension through December 2, 2026 to regain compliance with Nasdaq Listing Rule 5550(b)(1).

As previously disclosed, on June 5, 2026, Nasdaq notified the Company that it did not satisfy Nasdaq Listing Rule 5550(b)(1), which requires a listed company to maintain a minimum of $2.5 million in stockholders’ equity. At that time, the Company also did not satisfy the alternative continued listing standards based on market value of listed securities or net income from continuing operations.

Under the terms of the extension, the Company must complete its compliance initiatives and publicly demonstrate compliance with the applicable stockholders’ equity requirement on or before December 2, 2026. Nasdaq will continue to monitor the Company’s ongoing compliance with the requirement, including through the Company’s next periodic report.

The Company intends to continue pursuing its compliance initiatives within the extension period. The extension does not constitute a determination that the Company has regained compliance with Nasdaq’s continued listing requirements, and there can be no assurance that the Company will regain or maintain compliance. If the Company does not satisfy the terms of the extension, Nasdaq may issue a written determination to delist the Company’s common stock, which the Company would have the right to appeal to a Nasdaq Hearings Panel.

About Exicure, Inc.

Exicure, Inc. is a biotechnology company currently pursuing strategic initiatives designed to strengthen its financial position, maximize the value of its assets and establish a foundation for future investment and business growth.

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding the Company’s plans and ability to complete its compliance initiatives and regain and maintain compliance with Nasdaq’s continued listing requirements.

Forward-looking statements are based on the Company’s current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include the Company’s ability to complete its planned initiatives, Nasdaq’s acceptance of the Company’s evidence of compliance, the Company’s ability to regain and maintain compliance with Nasdaq’s continued listing requirements, and the other risks described in the Company’s filings with the Securities and Exchange Commission.

The Company undertakes no obligation to update any forward-looking statement except as required by applicable law.

Contact

Exicure, Inc.

Email: pr@exicuretx.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What specific Nasdaq rule is Exicure required to comply with?

Exicure must comply with Nasdaq Listing Rule 5550(b)(1), which requires a listed company to maintain a minimum of $2.5 million in stockholders’ equity.

What must Exicure do within the extension period?

Exicure must complete its compliance initiatives and publicly demonstrate compliance with the applicable stockholders’ equity requirement on or before December 2, 2026.

How will Nasdaq monitor Exicure’s progress toward compliance?

Nasdaq will continue to monitor Exicure’s ongoing compliance with the stockholders’ equity requirement, including through the Company’s next periodic report.

What happens if Exicure does not meet the terms of the extension?

If Exicure does not satisfy the terms of the extension, Nasdaq may issue a written determination to delist the Company’s common stock, which Exicure would have the right to appeal to a Nasdaq Hearings Panel.

Does the extension mean Exicure is currently in compliance with Nasdaq rules?

The company states that the extension does not constitute a determination that it has regained compliance with Nasdaq’s continued listing requirements, and there can be no assurance that it will regain or maintain compliance.